Cataract surgery is the most common surgical intervention worldwide.

 

Post-surgery management of patients is key to preventing infection and treating inflammation. An additional key priority for the surgeon is to help the patients quickly recover their vision.

 

NTC has developed an innovative drug to appropriately manage the prevention of infection and to treat inflammation in patients after cataract surgery. In addition, NTC offers new products aimed at quickly restoring patients’ visual acuity after surgery (see section “Corneal edema”).

 

LEGENDA

DROPS
DROPS
GAUZE
SINGLE PACKED GAUZE
SINGLE DOSE
SINGLE DOSE
EYE COMPRESS
EYE COMPRESS
PRESERVATIVE FREE
PRESERVATIVE FREE
MULTI DOSE
MULTI DOSE
MEDICAL DEVICE
MEDICAL DEVICE
PATCH
PATCH
IRIDYA
IRIDYA

NTC portfolio in Eye Surgery

BLEFASTOP
Hy-Ter 5% (Hyaluronic acid +Tea tree oil), Aloe barbadensis
GAUZEEYE COMPRESS
TIABLO
Tiab 1% (Titanium+Silver), Xanthan gum, Dimethicone
GAUZE
IMPERIAL PURO
HA 0.2% w/o phosphates
DROPSMULTI DOSEPRESERVATIVE FREEMEDICAL DEVICEIRIDYA
PUROFLOG
Ectoin® 2%, Hydroxyethyl cellulose 0.8%
DROPSSINGLE DOSEPRESERVATIVE FREEMEDICAL DEVICE
SKUDO
Ocular patch with aeration holes, hypoallergenic
and self-adhesive, double sterilization
MEDICAL DEVICEPATCH